{"expires": 1766442942, "value": "{\"moat_score\": 0.2, \"reasoning\": \"COR stock has a high P/E ratio and high debt/equity ratio, indicating potential overvaluation and financial risk. The gross margin, operating margin, and ROE are relatively low, suggesting limited pricing power and profitability. As a healthcare stock, COR may face intense competition and regulatory pressures, further eroding its competitive advantage.\"}"}